Head and neck cancer trials in Netherlands
31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Where
- Amsterdam, Groningen, Maastricht
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07276399 · EU 2025-521917-24-00 - Phase 1/2Taking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Amsterdam, Nijmegen, Utrecht
- Age
- 18 years and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 2Taking peopleA Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
- Where
- Groningen, Nijmegen
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT07807163 · EU 2026-526741-10-00 - No phaseTaking peopleOutcome Prediction in Head&Neck Cancer Patients After Radiotherapy
- Where
- Maastricht
- Age
- 18 years and over
- People
- 1,000
- Run by
- Maastricht Radiation Oncology
See details and how to joinNCT01985984 - No phaseNot yet taking people in NetherlandsOff-line Adaptive Proton Therapy
- Where
- Groningen
- Age
- 16 years and over
- People
- 100
- Run by
- University Medical Center Groningen
See details and how to joinNCT07866547 - Phase 3Taking peopleIMCISION: Towards organ preservation and cure via ultra-short immunotherapy in advanced oral cancer. The IMCISION II trial, an investigator-initiated multicentre randomised phase 3 trial
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 308
- Run by
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2025-522500-24-00 · EU 2025-522500-24-00 - No phaseTaking peopleTo Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
- Where
- Groningen
- Age
- 18 years and over
- People
- 850 worldwide
- Run by
- XEOS Medical
See details and how to joinNCT06970275 - Phase 2Taking peopleFluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 27
- Run by
- Erasmus Medical Center
See details and how to joinNCT05752149 - Phase 1Taking peopleThermotherapy for Head and Neck Cancer Patients
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 30
- Run by
- Erasmus Medical Center
See details and how to joinNCT07690618 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Amsterdam, Rotterdam
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - Phase 1Taking peopleA Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors
- Where
- Amsterdam, Nijmegen
- Age
- 18 years and over
- People
- 21
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2024-516870-31-00 · EU 2024-516870-31-00 - Phase 2/3Not yet taking people in NetherlandsThe Surf trial
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 40
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2025-523898-42-00 · EU 2025-523898-42-00 - Phase 3Taking peopleA Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Where
- Amsterdam, Nijmegen
- Age
- 18 years and over
- People
- 410 worldwide
- Run by
- AVEO Pharmaceuticals, Inc.
See details and how to joinNCT06064877 · EU 2023-505606-42-00 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Amsterdam, Deventer, Leeuwarden, Nijmegen, Utrecht
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 2/3Taking peopleContrast-enhanced Ultrasound for Sentinel Node Detection
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 91
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT07310758 - Early phase 1Taking peoplePET-imaging of Two Vartumabs in Patients With Solid Tumors
- Where
- Groningen
- Age
- 18 years and over
- People
- 32
- Run by
- Var2 Pharmaceuticals
See details and how to joinNCT06645808 · EU 2024-513827-18-00 - Phase 3Taking peoplePersonalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.
- Where
- Amsterdam, Arnhem, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 242
- Run by
- Radboud University Medical Center
See details and how to joinNCT05333523 - Phase 1/2Taking peoplePhase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
- Where
- Maastricht, Rotterdam
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT04954599 - No phaseTaking peopleTelemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Standard of Care
- Where
- Groningen
- Age
- 18 years and over
- People
- 140
- Run by
- University Medical Center Groningen
See details and how to joinNCT06940505 - No phaseTaking peopleFeasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 100
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06691776 - Phase 2Taking peopleTowards Cure Via Only Ultra-short ICB in CSCC
- Where
- Amsterdam, Maastricht, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 41
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06823479 · EU 2024-516152-17-00 - Phase 1/2Not yet taking people in NetherlandsMolecular Imaging of DNA Damage Response by [18F]-Olaparib PET
- Where
- Groningen
- Age
- 18 years and over
- People
- 10
- Run by
- University Medical Center Groningen
See details and how to joinNCT06482307 · EU 2024-511962-34-00